,
“Beneficial effect on non-inherited maternal antigens on graft survival in pediatric renal transplantation,”, J Am Soc Nephrol, vol. 7, p. 1917, 1996.
, “Clinical correlates of chronic rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study,”, Transplantation, vol. 61, pp. 1054-58, 1996.
, “Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study.”, Transplantation, vol. 61, no. 7, pp. 1054-8, 1996.
, “Clinical trials referral resource. Breast cancer and prostate cancer.”, Oncology (Williston Park), vol. 10, no. 1, p. 100, 102, 1996.
, “Clinical Trials Referral Resource. Cancer Chemoprevention and Control Trials”, Oncology (Williston Park), vol. 10, pp. 499-503, 1996.
, “Clinical trials referral resource. Cancer chemoprevention and control trials.”, Oncology (Williston Park), vol. 10, no. 4, pp. 499-500, 1996.
, “Clinical trials referral resource. Cancer chemoprevention trials,”, Oncology, vol. 10, pp. 324-5, 1996.
, “Clinical trials referral resource. Clinical trials for children with acute leukemia,”, Oncology, vol. 10, pp. 1662-6, 1996.
, “Clinical trials referral resource. Clinical trials for children with acute leukemia.”, Oncology (Williston Park), vol. 10, no. 11, pp. 1662, 1665-6, 1996.
, “Clinical trials referral resource. Clinical trials in the CNS Consortia,”, Oncology, vol. 10, pp. 1183-4, 1996.
, “Clinical trials referral resource. Clinical trials in the CNS Consortia.”, Oncology (Williston Park), vol. 10, no. 8, pp. 1183-4, 1996.
, “Clinical trials referral resource. Clinical trials using bryostatin-1,”, Oncology, vol. 10, pp. 740-2, 1996.
, “Clinical trials referral resource. Clinical trials using bryostatin-1.”, Oncology (Williston Park), vol. 10, no. 5, pp. 740-2, 1996.
, “Clinical trials referral resource. Clinical trials using compound 506U78,”, Oncology, vol. 10, pp. 1831-2, 1996.
, “Clinical trials referral resource. Clinical trials using compound 506U78.”, Oncology (Williston Park), vol. 10, no. 12, pp. 1831-2, 1996.
, “Clinical trials referral resource. Clinical trials using gemcitabine,”, Oncology, vol. 10, pp. 1662-6, 1996.
, “Clinical trials referral resource. Clinical trials using gemcitabine.”, Oncology (Williston Park), vol. 10, no. 6, pp. 855-6, 1996.
, “Clinical trials referral resource. Clinical trials using thalidomide.”, Oncology (Williston Park), vol. 10, no. 10, p. 1498, 1501, 1996.
, “Clinical trials referral resource. Clinical trials using thalidomide,”, Oncology, vol. 10, pp. 1498-1501, 1996.
, “Clinical trials referral resource. Clinical trials with tomudex,”, Oncology, vol. 10, pp. 1041-2, 1996.
, “Clinical trials referral resource. Clinical trials with tomudex.”, Oncology (Williston Park), vol. 10, no. 7, pp. 1041-2, 1996.
, “Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.”, J Rheumatol Suppl, vol. 44, pp. 64-8, 1996.
, “Comparing methods for calculating confidence intervals for vaccine efficacy.”, Stat Med, vol. 15, no. 21-22, pp. 2379-92, 1996.
, “Disease clusters in structured environments,”, Stat Med, vol. 15, pp. 851-71, 1996.
,